Involvement of genetic factors in the response to a variable-dosing ranibizumab treatment regimen for age-related macular degeneration.
about
Resistance to antivascular endothelial growth factor treatment in age-related macular degenerationImpact of loading phase, initial response and CFH genotype on the long-term outcome of treatment for neovascular age-related macular degenerationGenetic risk, ethnic variations and pharmacogenetic biomarkers in age-related macular degeneration and polypoidal choroidal vasculopathyAssociation between variant Y402H in age-related macular degeneration (AMD) susceptibility gene CFH and treatment response of AMD: a meta-analysis.Pharmacogenetics for genes associated with age-related macular degeneration in the Comparison of AMD Treatments Trials (CATT)Pharmacogenetic associations with long-term response to anti-vascular endothelial growth factor treatment in neovascular AMD patientsGenetic insights into age-related macular degeneration: controversies addressing risk, causality, and therapeutics.Effects of Vitreomacular Traction on Ranibizumab Treatment Response in Eyes with Neovascular Age-related Macular DegenerationGenetic studies of age-related macular degeneration: lessons, challenges, and opportunities for disease management.Initial non-responders to ranibizumab in the treatment of age-related macular degeneration (AMD)Predictors of visual response to intravitreal bevacizumab for treatment of neovascular age-related macular degenerationA pharmacogenetics study to predict outcome in patients receiving anti-VEGF therapy in age related macular degeneration.Influence of seasonal sunlight intensity and iris color on the anti-VEGF therapy for neovascular age-related macular degenerationThe effect of CFH polymorphisms on the response to the treatment of age-related macular degeneration (AMD) with intravitreal ranibizumab.Personalized Medicine in Ophthalmology: From Pharmacogenetic Biomarkers to Therapeutic and Dosage Optimization.Mechanism of inflammation in age-related macular degenerationComplement pathway biomarkers and age-related macular degeneration.Pharmacogenetics and age-related macular degeneration.Risk factors and biomarkers of age-related macular degeneration.A prospective multicenter study on genome wide associations to ranibizumab treatment outcome for age-related macular degeneration.Exploring the Use of Molecular Biomarkers for Precision Medicine in Age-Related Macular Degeneration.
P2860
Q27015781-CDA6FAC9-F9D6-4A8C-8A80-615B89A8010AQ28728817-BF991A6C-6031-4116-BCD6-61C332A41239Q33645265-DAF48421-6D70-4981-A299-7187B062CE29Q34384420-EB4BE713-F323-4DA7-8352-E2D700E2C073Q34556444-62195AE1-B7D6-48EC-A395-D062DFD29CD8Q34781693-AB9D9DF4-67F8-4443-A3CD-F2080AB78FB9Q36084168-2B101775-BF3D-4D76-9489-7FC1FF64CF56Q36342997-702B086D-D9C5-4CC0-8B65-1C5A33163AE2Q36445951-A26E9F4D-12C9-43AD-9A5D-50A7717F7679Q37053909-4745E8C0-4C47-4367-B42F-5547F4B99BBAQ37166529-7C35A6DD-0DFD-45A8-BD0E-C2DA10B41A66Q37232214-21666E42-AB2D-4C92-AE61-3E85E68FAD7AQ37250974-36B2344C-ED65-4479-ACF8-35B6DC451594Q37407241-86DD9562-5010-459C-B205-F1469820ACF9Q37627442-F25FBED6-7B63-4D32-A1FC-9C806B056741Q38064846-DEFCBEA5-660C-44D9-96D9-853EB47C642BQ38614012-6F4364AA-9DB3-4498-9D3D-770257AEEFA4Q38791691-A5AD0227-C82B-4681-8711-72BDB067F9CDQ38828895-230549CE-4512-40FC-A77B-0328134267C9Q41504310-F4663FDF-C767-4355-A9A7-1D069F722692Q52559837-D7BC7429-7381-43FB-B519-F37E62ABE10D
P2860
Involvement of genetic factors in the response to a variable-dosing ranibizumab treatment regimen for age-related macular degeneration.
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Involvement of genetic factors ...... -related macular degeneration.
@ast
Involvement of genetic factors ...... -related macular degeneration.
@en
Involvement of genetic factors ...... -related macular degeneration.
@nl
type
label
Involvement of genetic factors ...... -related macular degeneration.
@ast
Involvement of genetic factors ...... -related macular degeneration.
@en
Involvement of genetic factors ...... -related macular degeneration.
@nl
prefLabel
Involvement of genetic factors ...... -related macular degeneration.
@ast
Involvement of genetic factors ...... -related macular degeneration.
@en
Involvement of genetic factors ...... -related macular degeneration.
@nl
P2093
P2860
P1433
P1476
Involvement of genetic factors ...... -related macular degeneration.
@en
P2093
Andrzej Palucha
Anna Nowinska
Edward Wylegala
Jaroslaw Pilat
Slawomir J Teper
P2860
P304
P577
2010-12-07T00:00:00Z